Gabapentin Should NOT Be Discontinued Abruptly
Gabapentin should be tapered gradually rather than stopped abruptly, particularly in patients on epilepsy treatment or those taking higher doses, due to the risk of withdrawal-precipitated seizures and withdrawal symptoms. 1
Key Evidence from FDA Labeling
The FDA label explicitly warns that "antieepiletic drugs should not be abruptly discontinued because of the possibility of increasing seizure frequency" 1. In epilepsy trials, status epilepticus occurred in 0.6% of gabapentin-treated patients, and among all epilepsy studies, 1.5% experienced status epilepticus 1.
Additionally, the FDA acknowledges postmarketing reports of withdrawal symptoms occurring "shortly after discontinuing higher than recommended doses," including agitation, disorientation, and confusion that resolved after restarting gabapentin 1. Most affected individuals had histories of polysubstance abuse, but withdrawal can occur in any patient 1.
Clinical Manifestations of Withdrawal
Documented withdrawal symptoms include:
- Anxiety, insomnia, nausea, pain, and sweating (most frequently reported) 1
- Severe neurological symptoms: confusion, agitation, restlessness, disorientation 2
- Akathisia (restless limb movements and inner restlessness) 3
- Altered mental status requiring intensive care 4
Symptom onset typically occurs within 12 hours to 7 days of discontinuation 5, though symptoms can appear as early as 2 days after stopping 2.
Risk Factors for Problematic Withdrawal
Higher risk patients include:
- Epilepsy patients (risk of seizure exacerbation) 1
- Those on doses >3000 mg/day (average in abuse cases: 3000-8000 mg/day) 5
- Patients with substance abuse history (though withdrawal occurs in others too) 1, 5
- Treatment duration as short as 3-4 weeks can lead to withdrawal 3
Management Algorithm
If discontinuation is necessary:
Gradual taper is essential - the guideline recommends titration periods of 3-8 weeks when initiating, suggesting similar caution when discontinuing 6
If withdrawal symptoms develop:
Benzodiazepines are NOT effective for gabapentin withdrawal symptoms 2
For severe cases with altered mental status:
Critical Pitfall
Do not assume withdrawal symptoms are from alcohol or benzodiazepines in polypharmacy patients - gabapentin withdrawal presents similarly but requires gabapentin reinitiation, not benzodiazepines 2. One case report documented a patient presumed to have alcohol withdrawal who failed benzodiazepine treatment but responded immediately to gabapentin reinitiation 2.
Special Consideration for Epilepsy
In epilepsy patients specifically, abrupt discontinuation poses direct seizure risk beyond withdrawal symptoms 1. The background seizure rate makes causality difficult to establish, but the FDA warns this risk applies to all antiepileptic drugs regardless of mechanism 1.